These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30840281)

  • 21. [Expression of microRNA-152 in colorectal cancer and its relationship with prognosis].
    Wang Y; Yuan W; Ma X; Ma J
    Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):763-766. PubMed ID: 27784461
    [No Abstract]   [Full Text] [Related]  

  • 22. Distinct expressions of microRNAs that directly target estrogen receptor α in human breast cancer.
    Yoshimoto N; Toyama T; Takahashi S; Sugiura H; Endo Y; Iwasa M; Fujii Y; Yamashita H
    Breast Cancer Res Treat; 2011 Nov; 130(1):331-9. PubMed ID: 21755340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of miRNA-9 and miRNA-34a as potential biomarkers for diagnosis of breast cancer in Iranian women.
    Orangi E; Motovali-Bashi M
    Gene; 2019 Mar; 687():272-279. PubMed ID: 30468908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Research on correlations of MiR-203 expression with onset and prognosis of bladder cancer.
    Huang Z; Liu G
    J BUON; 2019; 24(3):1210-1218. PubMed ID: 31424681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations of miR-146a and miR-146b expression and breast cancer in very young women.
    Li Y; Xu Y; Yu C; Zuo W
    Cancer Biomark; 2015; 15(6):881-7. PubMed ID: 26406414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased Cellular Levels of MicroRNA-9 and MicroRNA-221 Correlate with Cancer Stemness and Predict Poor Outcome in Human Breast Cancer.
    Cheng CW; Yu JC; Hsieh YH; Liao WL; Shieh JC; Yao CC; Lee HJ; Chen PM; Wu PE; Shen CY
    Cell Physiol Biochem; 2018; 48(5):2205-2218. PubMed ID: 30110679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical potential of miR-940 as a diagnostic and prognostic biomarker in breast cancer patients.
    Liu W; Xu Y; Guan H; Meng H
    Cancer Biomark; 2018; 22(3):487-493. PubMed ID: 29843213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lower expression of miR-218 in human breast cancer is associated with lymph node metastases, higher grades, and poorer prognosis.
    Ahmadinejad F; Mowla SJ; Honardoost MA; Arjenaki MG; Moazeni-Bistgani M; Kheiri S; Teimori H
    Tumour Biol; 2017 Aug; 39(8):1010428317698362. PubMed ID: 28857013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer.
    Kong Y; Ning L; Qiu F; Yu Q; Cao B
    Cancer Biomark; 2019; 24(4):477-483. PubMed ID: 30909187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression Analysis of MicroRNA-222 in Breast Cancer.
    Amini S; Abak A; Estiar MA; Montazeri V; Abhari A; Sakhinia E
    Clin Lab; 2018 Apr; 64(4):491-496. PubMed ID: 29739090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of miR-199b-5p is correlated with poor prognosis for breast cancer patients.
    Fang C; Wang FB; Li Y; Zeng XT
    Biomed Pharmacother; 2016 Dec; 84():1189-1193. PubMed ID: 27788476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis.
    Yan LX; Huang XF; Shao Q; Huang MY; Deng L; Wu QL; Zeng YX; Shao JY
    RNA; 2008 Nov; 14(11):2348-60. PubMed ID: 18812439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer.
    Gwak JM; Kim HJ; Kim EJ; Chung YR; Yun S; Seo AN; Lee HJ; Park SY
    Breast Cancer Res Treat; 2014 Aug; 147(1):39-49. PubMed ID: 25086633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between down-expression of miR-431 and clinicopathological significance in HCC tissues.
    Pan L; Ren F; Rong M; Dang Y; Luo Y; Luo D; Chen G
    Clin Transl Oncol; 2015 Jul; 17(7):557-63. PubMed ID: 25775917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial.
    Müller V; Gade S; Steinbach B; Loibl S; von Minckwitz G; Untch M; Schwedler K; Lübbe K; Schem C; Fasching PA; Mau C; Pantel K; Schwarzenbach H
    Breast Cancer Res Treat; 2014 Aug; 147(1):61-8. PubMed ID: 25086636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer.
    Mu YP; Tang S; Sun WJ; Gao WM; Wang M; Su XL
    Asian Pac J Cancer Prev; 2014; 15(20):8893-900. PubMed ID: 25374225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of miR-139 as a surrogate marker for tumor aggression in breast cancer.
    Dai H; Gallagher D; Schmitt S; Pessetto ZY; Fan F; Godwin AK; Tawfik O
    Hum Pathol; 2017 Mar; 61():68-77. PubMed ID: 27864119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.
    Inoue T; Iinuma H; Ogawa E; Inaba T; Fukushima R
    Oncol Rep; 2012 Jun; 27(6):1759-64. PubMed ID: 22407237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-4728-3p could act as a marker of HER2 status.
    Li H; Zhou X; Zhu J; Cheng W; Zhu W; Shu Y; Liu P
    Cancer Biomark; 2015; 15(6):807-14. PubMed ID: 26406406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low expression of miR-597 is correlated with tumor stage and poor outcome in breast cancer.
    Zhang XY; Liu DJ; Yuan RB; Zhang DH; Li SR; Zhang SH; Zhang LY
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):456-460. PubMed ID: 29424903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.